可孚医疗 01187Stock Information

Stock Information · New Rules (after Aug 2025)
// Company Overview //
Stock Name可孚医疗
Stock Code01187
Company Full Name可孚医疗
Industry醫療保健
Principal Activities公司是中國的家用醫療器械企業,根據弗若斯特沙利文的資料,按2024年的國內收入計,公司在中國所有家用醫療器械企業中排名第二,市場份額達2.1%。
Listing Date2026-05-06
Listing Rules EraNew Rules (after Aug 2025)
Listing Rules ChapterNo data
Weighted Voting Rights (WVR)No
Registered Address (Mainland China)中國湖南省長沙市雨花區環保東路一段87號
Business Address (Hong Kong)No data
Place of IncorporationNo data
Listing MethodNo data
Listing BoardMain Board
Websitehttps://www.cofoe.com.cn/
Share Registrar卓佳证券登记有限公司 (Tricor Investor Services Limited)
Registrar Contact(852)2980 1333
A-Share/US Dual ListingNo
// Offering Information //
Offering Mechanism 机制B
Clawback Tiers机制B不设回拨,公开发售占比维持10.0%
Offer Period2026-04-27 to 2026-04-30
Offer PriceHK$ 39.33 / shares
Offer Price RangeFinal offer price only, no range
Lot Size100 shares
Entry ThresholdHK$ 3,933
Par ValueNo data
Global Offering Shares27,000,000
HK Public Offering Shares2,700,000 (10.0%)
International Placing Shares24,300,000 (90.0%)
Offer RatioNo data
Total Shares Post-IPONo data
Total Global Offering SizeHK$ 1,061,910,000
Public Offering SizeHK$ 106,191,000 (10.0%)
Oversubscription Multiple399.1x
Valid Applications105,939
Accepted Applications
ReallocationNo
Total Funds RaisedHK$ 106,191,000
Greenshoe (Over-allotment Option)No
Final Public Offering Share10.0%
// Valuation & Financials //
Market Cap (at Offer Price)HK$ 0
Pre-IPO Valuation (Last Round)No data
P/E Ratio22.59
Profit/Loss StatusNo data
Period-End Cash BalanceNo data
Listing Expenses~HK$ 54,900,000
Listing Expenses / Funds RaisedNo data
Total Pre-IPO InvestmentNo data
// First Day Performance
First Day CloseLoading...
First Day OpenHK$ 39.84
First Day Change-1.09%
First Day Volume11185500.0
First Day Turnover428006000.0
// Price Chart //
Loading...
// Use of Proceeds
Use of Proceeds1、30.0%或約302.1百萬港元將用于全球拓展; 2、30.0%或約302.1百萬港元將用于持續的產品研發及技術創新,包括人工智能及物聯網應用; 3、20.0%或約201.4百萬港元將用于拓展國內銷售渠道及經銷網絡; 4、10.0%或約100.7百萬港元將用于品牌推廣及營銷活動; 5、10.0%或約100.7百萬港元將用于營運資金及一般公司用途。
// Underwriting Syndicate //
联席保荐人 (2)
华泰金融控股(香港)有限公司 法国巴黎证券(亚洲)有限公司
整体协调人 (3)
华泰金融控股(香港)有限公司 法国巴黎证券(亚洲)有限公司 富途证券国际(香港)有限公司
联席账簿管理人 (3)
华泰金融控股(香港)有限公司 法国巴黎证券(亚洲)有限公司 富途证券国际(香港)有限公司
联席牵头经办人 (3)
华泰金融控股(香港)有限公司 法国巴黎证券(亚洲)有限公司 富途证券国际(香港)有限公司
// Cornerstone Investors // Allotment Results Announcement
#Investor NameShares Subscribed% of Offer Shares% of Total SharesLock-up PeriodEst. Unlock Date
1 長沙械字號醫療投資有限公司 85,079,923 36.07% 2026-11-05 2026-11-05
2 張敏(「張先生」) 12,114,881 5.14% 2026-11-05 2026-11-05
3 長沙科源同創創業投資合夥企業 12,114,881 5.14% 2026-11-05 2026-11-05
4 聶娟(「聶女士」) 3,485,739 1.48% 2026-11-05 2026-11-05
5 長沙雨豐科技有限公司(「長沙雨豐」) 1,390,700 5.15% 0.59%
6 (就遠信投資場外掉期而言) 1,296,000 4.80% 0.55%
7 盤京港景投資基金(「盤京基金」) 995,400 3.69% 0.42%
8 (「漢清達實業」) 497,700 1.84% 0.21%
9 大成國際資產管理有限公司(「大成國際」) 398,100 1.47% 0.17%
10 中康科技控股有限公司(「中康科技」) 398,100 1.47% 0.17%
// Directors & Management //
Chairman張敏
Company Secretary薛小橋,夏正靜
No director data available.
// Major Shareholders //
Major Shareholders & Holdings長沙械字號醫療投資有限公司(36.07%),張敏(5.14%)
// Allotment Benchmarks //
Pool A (Small Subscriptions)
Shares AppliedApplicantsAllotteesExpected Lots
100 36,115 1,806 0.05
200 23,947 1,592 0.07
300 4,338 341 0.08
400 2,377 210 0.09
500 3,566 346 0.10
600 1,613 169 0.11
700 1,122 125 0.11
800 1,239 146 0.12
900 882 109 0.12
1,000 7,327 943 0.13
1,500 2,064 314 0.15
2,000 1,745 299 0.17
2,500 1,517 285 0.19
3,000 1,246 252 0.20
3,500 602 130 0.22
4,000 663 151 0.23
4,500 446 107 0.24
5,000 1,393 347 0.25
6,000 793 213 0.27
7,000 678 194 0.29
8,000 653 198 0.30
9,000 590 187 0.31
10,000 3,384 1,120 0.33
20,000 1,439 633 0.44
30,000 940 488 0.51
40,000 573 335 0.60
50,000 521 334 0.65
60,000 406 281 0.72
70,000 332 244 0.70
80,000 331 257 0.80
90,000 225 184 0.81
100,000 1,364 1,160 0.90
Pool B (Large Subscriptions)
Shares AppliedApplicantsAllotteesExpected Lots
200,000 798 798 6.00
300,000 176 126 7.80
400,000 104 84 8.80
500,000 91 91 10.00
600,000 69 60 12.00
700,000 39 2 13.30
800,000 23 23 14.40
900,000 15 4 15.30
1,000,000 71 20 16.00
1,350,000 122 53 20.25
Offer Ratio
Allotment Benchmarks
Disclaimer & Risk Warning

Site Nature: This website (cibo.qizai.ai) is an independent technology product showcase platform established by Panda Securities Limited (CE Number: BNC380). This website itself and all content displayed herein do not constitute and are not involved in any regulated activity or licensed service.

Not Investment Advice: The data on this page is automatically extracted from prospectus PDFs by AI and may contain omissions or errors. Some data is supplemented from HKEX New Listing Reports ([HKEX]). All information and data on this page are sourced from prospectuses and related historical documents, are not real-time data, and will not be automatically updated, reflecting historical information at the time of prospectus publication. All content is provided solely for AI tool analysis learning exchange and technical reference purposes, and absolutely does not constitute any investment advice, offer to buy or sell, solicitation, recommendation, or guarantee. The output of this AI analysis tool should not be interpreted as investment opinion.

Decision Responsibility: Users should make investment decisions based on their own independent judgment and consult independent licensed financial advisors when needed. Neither the Company nor this AI analysis tool shall bear any responsibility for any investment decisions made by users based on the information on this page.

Separation from Panda Securities Official Website: The content of this website is strictly distinct from the SFC-regulated licensed services provided by Panda Securities' official website (fafa.hk). No securities trading or account opening or other regulated operations can be conducted through this website.

Panda Securities Limited is a licensed corporation regulated by the Hong Kong SFC (CE Number: BNC380) and a Hong Kong Exchange Participant (Participant ID: 02229). Use of this website constitutes acceptance of this disclaimer.

Cibo — IPO & Market Data Analytics